Replies to post #535571 on NorthWest Biotherapeutics Inc (NWBO)

[georgebailey]

Sub A- 100% agree. Nwbo/Merck(?) control the uplisting via series C pricing. All that’s left is whether they think nwbo valuation is 5B today. But hold on a minute, what if the value at 10B today—-hmmmm-if UK mfg approval comes this year the 10B valuation is very possible ignoring combos, Direct, platform….etc.